Sort
11,323 grants matching “glioblastoma”
Clinical efficacy of the antitumor agent ONC201 in GBM
$847,452Wolfgang Oster · Oncoceutics, Inc. · R44 · FY2015 · CA
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
$845,606Alain Charest · Tufts Medical Center · R01 · FY2014 · CA
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
$845,062Darell D Bigner · Duke University · R35 · FY2020 · CA
Multi-omic CSF Assay for the Diagnosis of Brain Cancers
$844,210Brian Coe · Belay Diagnostics, Llc · R42 · FY2025 · NS
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
$843,283Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
$843,249David M. Ashley · Duke University · U19 · FY2022 · CA
Mechanisms of Parkinson Disease and Related Disorders
$842,411David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Novel therapeutic approach in treatment of glioblastoma using sustained delivery of Connxin43 carboxy-terminal peptide encapsulated in biodegradable nanoparticles in combination with temozolomide
$841,361Christina Grek · Xequel Bio, Inc. · R44 · FY2018 · CA
Role of the Perivascular Microenvironment in Primary and Metastatic Brain Tumors
$841,065Eric C Holland · Fred Hutchinson Cancer Research Center · U54 · FY2015 · CA
Rb TS inhibition dedifferentiates astrocytes leading to Astrocytoma initiation
$840,990Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
SapC-DOPS nanovesicles for Treating Glioblastoma Multiforme
$840,956Kevin Xu · Bexion Pharmaceuticals, Inc. · R44 · FY2011 · CA
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
$840,430Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Biomechanical properties of chromatin in cancer and normal cells
$839,808Yamini P Dalal · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
$838,914William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Advancing treatment and understanding of immunotherapy in glioblastoma
$838,812Nicholas A Butowski · University Of California, San Francisco · U19 · FY2025 · CA
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma
$836,753Tracy T Batchelor · Brigham And Women'S Hospital · U19 · FY2024 · CA
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
$836,369David M. Ashley · Duke University · U19 · FY2025 · CA
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing
$834,674Charles M Perou · Univ Of North Carolina Chapel Hill · U24 · FY2010 · CA
Microenvironmental regulation of glioblastoma radiosensitivity
$834,513Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION INTERROGATION IN CANCER
$834,276Haian Fu · Emory University · U01 · FY2014 · CA
High Throughput Protein-Protein Interaction Interrogation in Cancer
$834,276Haian Fu · Emory University · U01 · FY2014 · CA
Role of Neurotrophins in the Development of the Mammalian Nervous System
$834,125Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Biogenesis of Exosomes, Secretion, and Trafficking in Alzheimer's Disease
$832,623Robert A Rissman · University Of California, San Diego · R56 · FY2017 · AG
Patient-specific predictive modeling that integrates advanced cancer imaging
$830,694Paul E Kinahan · University Of Washington · R01 · FY2014 · CA
Methods to build and annotate tissue atlases using spatial genomic data
$829,659Barbara Engelhardt · J. David Gladstone Institutes · R01 · FY2025 · HG